SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000014272-19-000192
Filing Date
2019-10-31
Accepted
2019-10-31 08:01:13
Documents
17
Period of Report
2019-10-31
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K q32019earningsrelease8.htm   iXBRL 8-K 60875
2 PRESS RELEASE OF BRISTOL-MYERS SQUIBB COMPANY DATED OCTOBER 31, 2019 q32019ex991.htm EX-99.1 522789
3 CERTAIN SUPPLEMENTAL INFORMATION q32019ex992.htm EX-99.2 2016885
9 bmslogo2019a02.jpg GRAPHIC 79779
  Complete submission text file 0000014272-19-000192.txt   2986838

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bmy-20191031.xsd EX-101.SCH 5662
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bmy-20191031_cal.xml EX-101.CAL 750
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bmy-20191031_def.xml EX-101.DEF 8124
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bmy-20191031_lab.xml EX-101.LAB 38695
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bmy-20191031_pre.xml EX-101.PRE 19601
10 EXTRACTED XBRL INSTANCE DOCUMENT q32019earningsrelease8_htm.xml XML 8293
Mailing Address 430 E. 29TH STREET 14 FLOOR NEW YORK NY 10016
Business Address 430 E. 29TH STREET 14 FLOOR NEW YORK NY 10016 2125464000
BRISTOL MYERS SQUIBB CO (Filer) CIK: 0000014272 (see all company filings)

IRS No.: 220790350 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-01136 | Film No.: 191182159
SIC: 2834 Pharmaceutical Preparations